Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HELP | IMMX |
|---|---|---|
| Price | $10.51 | $9.49 |
| Change today | ▼ 2.32% | ▼ 1.56% |
| Market cap | $767.86M | $788.42M |
| Return, 3 months | +58.5% | -14.4% |
| Return, year to date | +28.5% | +81.5% |
| Return, 1 year | +67.9% | +273.6% |
| P/E (TTM) | -2.5 | -10.8 |
| P/B | 3.3 | 3.4 |
| P/E percentile vs own 5y | 27th | 13th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -94.3% | -74.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -86.9% | -34.2% |
| Analyst target vs. price | +235.8% | +170.5% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 36 | 33 |
| 30-day volatility | 75.9% | 58.8% |
| Max drawdown, 1 year | -55.6% | -39.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
